Cell and Gene Therapy Summit

Join multi-stakeholder dialogue, identifying the barriers to progress and charting the best path forward in global regulatory harmonization for cell and gene therapies.

Back to Agenda

Session 5: Genome Editing as a Platform

Session Chair(s)

Representative Invited

Irish Dental Association, Ireland

This discussion will explore genome editing as a platform technology in cell and gene therapy, learn about recent advancements in precision medicine, and assess its broader therapeutic applications and role in regenerative medicine. Attendees will gain insights into the challenges faced when scaling these therapies, regulatory and manufacturing considerations, and are encouraged to share their own experience and strategies for ensuring safety, efficacy, and accessibility.

Learning Objective :
Learn how genome editing functions as a platform technology in cell and gene therapy development
Differentiate key regulatory and manufacturing considerations for scaling genome-edited therapies
Discuss the potential challenges and opportunities in integrating genome editing into regenerative medicine

Speaker(s)

Speaker

Michael Lehmicke, MSc

Alliance for Regenerative Medicine, United States

Senior Vice President, Science and Industry Affairs

Have an account?